2Dumont O,Loufrani L,Henrion D.Key role of the NO-pathway and matrix metalloprotease-9 in high blood flow-induced remodeling of rat resistance arteries[J].Arteioscler Thromb Vasc Biol,2007,27(2):317-324.
3Newby A C.Matrix metalloproteinases regulate migration,proliferation,and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates[J].Cardiovasc Res,2006,69(3):614-624.
4Lemaitre V,Armiento J D.Matrixmetalloproteinase in development and disease[J].Birth Defcts Res C Embryo Today,2006,78(1):1-10.
6Wu M,Li Y G.The expression of CD40/CD40L and activities of matrix metalloproteinases in atherosclerotic rats[J].Mol Cell Biochem,2006,282(1-2):141-146.
7Luttun A,Lutgens E,Manderveld A,et al.Loss of matrix metalloproteinase-9 or matrix metalloproteinases-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth[J].Circulation,2004,109(11):1408-1414.
9Inokubo Y,Hanada H,Ishizaka H,et al.Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1are increased in the coronary circulation in patients with acute coronary syndrome[J].Am Heart J,2001,141(2):211-217.
10Higo S,Uematsu M,Yamagishi M,et al.Elevation of plasma matrix metalloproteinase-9 in the culprit coronary artery in patients with acute myocardial infarction:clinical evidence from distal protection[J].Circ J,2005,69(10):1180-1185.
